Healthcare - Biotechnology - NASDAQ - US
$ 1.06
-7.02 %
$ 6.79 M
Market Cap
-0.27
P/E
INCOME STATEMENT
0
REVENUE
-6.89 M
OPERATING INCOME
-7 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Adial Pharmaceuticals, Inc.
| Revenue | 0 |
| Cost Of Revenue | 564 |
| Gross Profit | -564 |
| Operating Expenses | 6.89 M |
| Operating Income | -6.89 M |
| Other Expenses | 114 K |
| Net Income | -7 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||||
| Cost Of Revenue | 564 | 60.5 K | 55.1 K | 564 | 565 | 563 | 565 | 565 | 565 |
| Gross Profit | 564 | 60.5 K | 55.1 K | 564 | 565 | 563 | 565 | 565 | 565 |
| OPERATING INCOME | |||||||||
| Operating Expenses | 6.9 | 13.3 | 17.7 | 10.9 | 8.2 | 7.0 | 1.0 | 0.4 | 0.8 |
| Selling, General and Administrative Expenses | 5.6 | 9.1 | 9.3 | 5.1 | 4.3 | 6.6 | 0.8 | 0.3 | 0.5 |
| Research and Development Expenses | 1.3 | 4.2 | 8.4 | 5.9 | 4.0 | 0.4 | 0.2 | 0.1 | 0.3 |
| Operating Income | (6.9) | (13.3) | (19.3) | (10.9) | (8.2) | (7.0) | (1.0) | (0.4) | (0.8) |
| PRE-TAX INCOME | |||||||||
| Interest Income Expense | 0 | (0.6) | 0 | 0 | 0 | 1.2 | 0.1 | 9.64 K | 0 |
| Total Other Income | (0.1) | 0.6 | (1.8) | 35 K | (0.3) | (4.6) | (0.1) | 9.39 K | 1.26 K |
| Pre-Tax Income | (7.0) | (12.7) | (19.5) | (10.9) | (8.6) | (11.6) | (1.1) | (0.4) | (0.8) |
| NET INCOME | |||||||||
| Tax Provision | 0 | 502 | 94.1 K | 32.5 K | 76.1 K | (3.5) | 367 | 9.64 K | 1.26 K |
| Net Income | (7.0) | (12.7) | (19.4) | (10.9) | (8.6) | (11.6) | (1.1) | (0.4) | (0.8) |
| EPS | 5.44 | 318 | 26.1 | 21.8 | 21.8 | 61.1 | 5.2 | 2.2 | 4.28 |